MGMT and central nervous system cancer: The probable positive response for temozolomide may be due to the low level of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT), demonstrated by our negative immunostaining, as absence of this enzyme in gliomas is associated with increased chemosensitivity [16].